119 related articles for article (PubMed ID: 31802038)
41. Changes in glucose metabolism based on 75-g oral glucose tolerance tests before and after surgery for adrenal Cushing's syndrome.
Tsurutani Y; Miyoshi K; Inoue K; Takiguchi T; Saito J; Omura M; Nishikawa T
Endocr J; 2019 Mar; 66(3):207-214. PubMed ID: 30674738
[TBL] [Abstract][Full Text] [Related]
42. Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters.
Akkus G; Evran M; Sert M; Tetiker T
Endocr Metab Immune Disord Drug Targets; 2019; 19(3):326-332. PubMed ID: 30306882
[TBL] [Abstract][Full Text] [Related]
43. Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment.
Mazzuco TL; Bourdeau I; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):203-10. PubMed ID: 19390321
[TBL] [Abstract][Full Text] [Related]
44. Echocardiographic alterations in patients with non-functioning adrenal incidentaloma.
Ermetici F; Dall'Asta C; Malavazos AE; Coman C; Morricone L; Montericcio V; Ambrosi B
J Endocrinol Invest; 2008 Jun; 31(6):573-7. PubMed ID: 18591893
[TBL] [Abstract][Full Text] [Related]
45. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
[TBL] [Abstract][Full Text] [Related]
46. Preclinical Cushing's syndrome in patients with an adrenal incidentaloma.
Tjan-Heijnen VC; Hermus AR; Kemink SA; Mudde AH; Pieters GF; Smals AG; Kloppenborg PW
Neth J Med; 1998 Mar; 52(3):111-5. PubMed ID: 9599968
[TBL] [Abstract][Full Text] [Related]
47. Effect of o,p'-DDD on cortisol metabolism in Cushing's syndrome of various etiology.
Koide Y; Inoue S; Murayama H; Kawai K; Yamashita K
Endocrinol Jpn; 1985 Oct; 32(5):615-24. PubMed ID: 3004927
[TBL] [Abstract][Full Text] [Related]
48. Could Lipid Profile be Used as a Marker of Autonomous Cortisol Secretion in Patients with Adrenal Incidentalomas?
Mintziori G; Georgiou T; Anagnostis P; Adamidou F; Efstathiadou Z; Panagiotou A; Kita M
Horm Metab Res; 2018 Jul; 50(7):551-555. PubMed ID: 29991085
[TBL] [Abstract][Full Text] [Related]
49. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.
Mantero F; Terzolo M; Arnaldi G; Osella G; Masini AM; Alì A; Giovagnetti M; Opocher G; Angeli A
J Clin Endocrinol Metab; 2000 Feb; 85(2):637-44. PubMed ID: 10690869
[TBL] [Abstract][Full Text] [Related]
50. Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment.
Kopf D; Westphal S; Luley CW; Ritter S; Gilles M; Weber-Hamann B; Lederbogen F; Lehnert H; Henn FA; Heuser I; Deuschle M
J Clin Psychopharmacol; 2004 Oct; 24(5):527-31. PubMed ID: 15349009
[TBL] [Abstract][Full Text] [Related]
51. Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma.
Papanastasiou L; Pappa T; Samara C; Apostolopoulou G; Tsiavos V; Markou A; Alexandraki K; Piaditis G; Chrousos G; Kaltsas G
Eur J Clin Invest; 2012 Nov; 42(11):1165-72. PubMed ID: 23078137
[TBL] [Abstract][Full Text] [Related]
52. Clinical and biochemical impact of BCL1 polymorphic genotype of the glucocorticoid receptor gene in patients with adrenal incidentalomas.
Tzanela M; Mantzou E; Saltiki K; Tampourlou M; Kalogeris N; Hadjidakis D; Tsagarakis S; Alevizaki M
J Endocrinol Invest; 2012 Apr; 35(4):395-400. PubMed ID: 21738001
[TBL] [Abstract][Full Text] [Related]
53. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.
Papanastasiou L; Alexandraki KI; Androulakis II; Fountoulakis S; Kounadi T; Markou A; Tsiavos V; Samara C; Papaioannou TG; Piaditis G; Kaltsas G
Clin Endocrinol (Oxf); 2017 Apr; 86(4):488-498. PubMed ID: 27992961
[TBL] [Abstract][Full Text] [Related]
54. Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study.
Debono M; Chadarevian R; Eastell R; Ross RJ; Newell-Price J
PLoS One; 2013; 8(4):e60984. PubMed ID: 23577182
[TBL] [Abstract][Full Text] [Related]
55. [Surgical excision of subclinical cortisol secreting incidentalomas: Impact on blood pressure, BMI and glucose metabolism].
Mauclère-Denost S; Duron-Martinaud S; Nunes M-; Gatta B; Fagour C; Rault A; Gosse P; Tabarin A
Ann Endocrinol (Paris); 2009 Sep; 70(4):211-7. PubMed ID: 19457469
[TBL] [Abstract][Full Text] [Related]
56. Relationship between thyroid nodules and non-functioning adrenal incidentalomas and their association with insulin resistance.
Arduc A; Isik S; Ozuguz U; Tutuncu YA; Kucukler FK; Ozcan HN; Berker D; Guler S
Endocr Res; 2014; 39(3):99-104. PubMed ID: 24152247
[TBL] [Abstract][Full Text] [Related]
57. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.
Chiodini I; Morelli V; Salcuni AS; Eller-Vainicher C; Torlontano M; Coletti F; Iorio L; Cuttitta A; Ambrosio A; Vicentini L; Pellegrini F; Copetti M; Beck-Peccoz P; Arosio M; Ambrosi B; Trischitta V; Scillitani A
J Clin Endocrinol Metab; 2010 Jun; 95(6):2736-45. PubMed ID: 20375210
[TBL] [Abstract][Full Text] [Related]
58. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
Tatsuno I; Uchida D; Tanaka T; Koide H; Shigeta A; Ichikawa T; Sasano H; Saito Y
Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
Tzanela M; Zianni D; Stylianidou Ch; Karavitaki N; Tsagarakis S; Thalassinos NC
Clin Endocrinol (Oxf); 2005 May; 62(5):597-602. PubMed ID: 15853831
[TBL] [Abstract][Full Text] [Related]
60. Adrenal reserve function after unilateral adrenalectomy in patients with primary aldosteronism.
Honda K; Sone M; Tamura N; Sonoyama T; Taura D; Kojima K; Fukuda Y; Tanaka S; Yasuno S; Fujii T; Kinoshita H; Ariyasu H; Kanamoto N; Miura M; Yasoda A; Arai H; Ueshima K; Nakao K
J Hypertens; 2013 Oct; 31(10):2010-7. PubMed ID: 23846863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
